A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides
- PMID: 18438816
- DOI: 10.1002/art.23470
A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides
Abstract
Objective: To establish a set of clinical and paraclinical criteria potentially useful as a diagnostic screening tool for polyarteritis nodosa (PAN).
Methods: The abilities of individual descriptive items to predict a diagnosis of PAN were evaluated by screening available data from 949 patients from the French Vasculitis Study Group database, including 262 with PAN and 687 with control vasculitides. Selected items were tested in a logistic regression model to establish a minimal set of nonredundant PAN-predictive criteria. The discriminative accuracy of these items and of the American College of Rheumatology (ACR) 1990 criteria were assessed by reapplying them to the initial patient sample and a subgroup restricted to PAN and microscopic polyangiitis (MPA) patients. A computer simulation procedure was conducted on artificially generated patient data to evaluate the usefulness of these criteria in predicting a diagnosis of PAN.
Results: The analysis resulted in the retention of 3 positive predictive parameters (hepatitis B virus antigen and/or DNA in serum, arteriographic anomalies, and mononeuropathy or polyneuropathy) and 5 negative predictive parameters (indirect immunofluorescence detection of antineutrophil cytoplasmic antibody; asthma; ear, nose, and throat signs; glomerulopathy; and cryoglobulinemia) for the criteria set. These criteria yielded 70.6% sensitivity for all control vasculitides and 89.7% for MPA controls, with 92.3% specificity for all controls and 83.1% for MPA controls. The discriminant abilities of this set of items outperformed the ACR 1990 criteria in all analytical situations, showing better robustness to variations in the prevalence of individual vasculitides.
Conclusion: The use of positive and negative discriminant criteria could constitute a sound basis for developing a diagnostic tool for PAN to be used by clinicians. Further prospective analyses and validations in different populations are needed to confirm these items as satisfactory diagnostic criteria.
Similar articles
-
Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment.Curr Opin Rheumatol. 1995 Jan;7(1):20-4. Curr Opin Rheumatol. 1995. PMID: 7718418 Review.
-
Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis.Br J Dermatol. 2008 Sep;159(3):615-20. doi: 10.1111/j.1365-2133.2008.08725.x. Epub 2008 Jul 19. Br J Dermatol. 2008. PMID: 18647311
-
Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosis.J Autoimmun. 2005 Mar;24(2):169-79. doi: 10.1016/j.jaut.2004.11.001. J Autoimmun. 2005. PMID: 15829409
-
Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.Arthritis Rheum. 2010 Feb;62(2):616-26. doi: 10.1002/art.27240. Arthritis Rheum. 2010. PMID: 20112401
-
[Polyarteritis nodosa].Nihon Rinsho. 1999 Feb;57(2):349-54. Nihon Rinsho. 1999. PMID: 10078003 Review. Japanese.
Cited by
-
Bilateral renal subcapsular hematoma caused by polyarteritis nodosa: a case report.CEN Case Rep. 2022 Nov;11(4):399-403. doi: 10.1007/s13730-022-00691-5. Epub 2022 Feb 16. CEN Case Rep. 2022. PMID: 35171449 Free PMC article.
-
Validation of the provisional seven-item criteria for the diagnosis of polyarteritis nodosa.Rheumatol Int. 2021 Sep;41(9):1651-1655. doi: 10.1007/s00296-021-04867-7. Epub 2021 Apr 27. Rheumatol Int. 2021. PMID: 33904958
-
Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa.Curr Rheumatol Rep. 2021 Feb 10;23(3):14. doi: 10.1007/s11926-021-00983-2. Curr Rheumatol Rep. 2021. PMID: 33569653 Review.
-
French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).Orphanet J Rare Dis. 2020 Dec 29;15(Suppl 2):351. doi: 10.1186/s13023-020-01621-3. Orphanet J Rare Dis. 2020. PMID: 33372616 Free PMC article. Review.
-
Polyarteritis nodosa with perirenal hematoma due to the rupture of a renal artery aneurysm.CEN Case Rep. 2021 May;10(2):244-249. doi: 10.1007/s13730-020-00552-z. Epub 2020 Nov 11. CEN Case Rep. 2021. PMID: 33175365 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
